MedTrace Logo

Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells

NCT06523543 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2026-03-13

No results posted yet for this study

Summary

Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.

Conditions

  • Pregnant Women

Interventions

PROCEDURE

Inclusion (Visit 1 - Week 7-16)

Extraction of cervico-vaginal sampling

DIAGNOSTIC_TEST

Second semester of pregnancy (Visit 2 - Week 20-24)

Ultrasound examination (determination of chromosomal sex)

DIAGNOSTIC_TEST

Third semester of pregnancy (Visit 3- Week 34)

Ultrasound examination (determination of chromosomal sex) if this has not be done during the Visit 2 or if a new determination correcting the previous one is provided.

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Vincent GATINOIS, MD · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-19
Primary Completion
2027-08-30
Completion
2028-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06523543 on ClinicalTrials.gov